Open Journal of Blood Diseases

Vol.5 No.4(2015), Paper ID 62422, 11 pages

DOI:10.4236/ojbd.2015.54008

 

Availability of Circulating MicroRNAs as a Biomarker for Early Diagnosis of Diffuse Large B-Cell Lymphoma

 

Katsushige Inada, Yasushi Okoshi, Yukiko Cho, Hitoaki Saito, Tatsuo Iijima, Mitsuo Hori, Hiroshi Kojima

 

Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Ibaraki, Japan
Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
Department of Medical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Pathology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Pathology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Ibaraki, Japan
Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
Department of Medical Oncology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan

 

Copyright © 2015 Katsushige Inada, Yasushi Okoshi, Yukiko Cho, Hitoaki Saito, Tatsuo Iijima, Mitsuo Hori, Hiroshi Kojima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Inada, K. , Okoshi, Y. , Cho, Y. , Saito, H. , Iijima, T. , Hori, M. and Kojima, H. (2015) Availability of Circulating MicroRNAs as a Biomarker for Early Diagnosis of Diffuse Large B-Cell Lymphoma. Open Journal of Blood Diseases, 5, 48-58. doi: 10.4236/ojbd.2015.54008.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.